Lithiofor, comprimés à libération prolongée

7680380610117 CH-38061 Tabletten
Lithiofor, comprimés à libération prolongée
Lithiofor, comprimés à libération prolongée
Lithiofor, comprimés à libération prolongée
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/06/2025
Patient information leaflet
Français
12/06/2025
Patient information leaflet
Italien
12/06/2025
Summary of Product Characteristics
Allemand
12/06/2025
Summary of Product Characteristics
Français
12/06/2025
Summary of Product Characteristics
Italien
12/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
660.0 MG Substance WIZUS
(N/A)
12.0 MMOL Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 15.75
Specialties list
Yes
Generic
No
SL addition date: 15/03/1976

Authorization holder

OM Pharma Suisse SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
38061
Drug name
Lithiofor, comprimés à liberation prolongée
Galenic form
RETT
ATC Code
N05AN01
Authorization status
Z
Dispensing category
A
First authorization
17/08/1973
Authorization expiration date
31/12/9999
IT Number
01.06.0.
Domain
Human medicine

Package details

Description (FR)
LITHIOFOR cpr ret 660 mg 30 pce
Description (DE)
LITHIOFOR Ret Tabl 660 mg 30 Stk
Market launch
17/08/1973
Narcotic (BTM)
No

Other package sizes (1)

LITHIOFOR cpr ret 660 mg 250 pce
250 TABL
GTIN: 7680380610384
View